https://www.selleckchem.com/pr....oducts/Temsirolimus.
05). Obstructive HCM patients also demonstrated higher KELA-avg (14.8 [10.6, 20.4] J/m3 vs. 33.4 [23.9, 61.3] J/m3, P less then 0.001) and KELA-peak (22.1 [15.9, 28.7] J/m3 vs. 57.2 [44.5, 121.4] J/m3, P less then 0.001) than non-obstructive HCM. MR severity was significantly correlated with KELA-avg (rho = 0.81, P less then 0.001) and KELA-peak (rho = 0.79, P less then 0.001). LVOT ∆PMRI was strongly correlated with KELA metrics in obstructive HCM (KELA-avg rho = 0.86, P less then 0.001; KELA-peak rho = 0.85, P less the